128 related articles for article (PubMed ID: 3871613)
1. Effect of mefloquine on hepatic drug metabolism in the rat: comparative study with primaquine.
Riviere JH; Back DJ
Biochem Pharmacol; 1985 Feb; 34(4):567-71. PubMed ID: 3871613
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of ethinyloestradiol and tolbutamide metabolism by quinoline derivatives in vitro.
Riviere JH; Back DJ
Chem Biol Interact; 1986 Oct; 59(3):301-8. PubMed ID: 3769058
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of tolbutamide metabolism by antimalarial drugs.
Karbwang J; Back DJ; Bunnag D; Breckenridge AM
Southeast Asian J Trop Med Public Health; 1988 Jun; 19(2):235-41. PubMed ID: 3227403
[TBL] [Abstract][Full Text] [Related]
4. [Therapeutic efficacy of a regimen of artesunate-mefloquine-primaquine treatment for Plasmodium falciparum malaria and treatment effects on gametocytic development].
Vásquez AM; Sanín F; Alvarez LG; Tobón A; Ríos A; Blair S
Biomedica; 2009 Jun; 29(2):307-19. PubMed ID: 20128355
[TBL] [Abstract][Full Text] [Related]
5. The effects of primaquine stereoisomers and metabolites on drug metabolism in the isolated perfused rat liver and in vitro rat liver microsomes.
Mihaly GW; Ward SA; Nicholl DD; Edwards G; Breckenridge AM
Biochem Pharmacol; 1985 Feb; 34(3):331-6. PubMed ID: 3970715
[TBL] [Abstract][Full Text] [Related]
6. Effect of a new 8-aminoquinoline antimalarial compound on hepatic microsomal mixed function oxidase system of mice.
Saxena N; Pandey VC; Puri SK; Dutta GP
Indian J Med Res; 1989 Sep; 89():330-3. PubMed ID: 2628296
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of hepatic microsomal enzymes by gossypol in the rat.
Ma XN; Back DJ
Contraception; 1984 Jul; 30(1):89-97. PubMed ID: 6478834
[TBL] [Abstract][Full Text] [Related]
8. Dipeptide derivatives of primaquine as transmission-blocking antimalarials: effect of aliphatic side-chain acylation on the gametocytocidal activity and on the formation of carboxyprimaquine in rat liver homogenates.
Portela MJ; Moreira R; Valente E; Constantino L; Iley J; Pinto J; Rosa R; Cravo P; do Rosário VE
Pharm Res; 1999 Jun; 16(6):949-55. PubMed ID: 10397619
[TBL] [Abstract][Full Text] [Related]
9. Absence of significant pharmacokinetic and pharmacodynamic interactions between artemether and quinoline antimalarials.
Na-Bangchang K; Karbwang J; Ubalee R; Thanavibul A; Saenglertsilapachai S
Eur J Drug Metab Pharmacokinet; 2000; 25(3-4):171-8. PubMed ID: 11420886
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of rat hepatic mixed function oxidases by antimalarial drugs: selectivity for cytochromes P-450 and P-448.
Thabrew MI; Ioannides C
Chem Biol Interact; 1984 Oct; 51(3):285-94. PubMed ID: 6488390
[TBL] [Abstract][Full Text] [Related]
11. Drug induced alterations in some rat hepatic microsomal components: a comparative study of four structurally different antimalarials.
Thabrew MI; Nashiru TO; Emerole GO
Comp Biochem Physiol C Comp Pharmacol Toxicol; 1985; 81(1):133-8. PubMed ID: 2861039
[TBL] [Abstract][Full Text] [Related]
12. In vitro inhibition studies of tolbutamide hydroxylase activity of human liver microsomes by azoles, sulphonamides and quinolines.
Back DJ; Tjia JF; Karbwang J; Colbert J
Br J Clin Pharmacol; 1988 Jul; 26(1):23-9. PubMed ID: 3203057
[TBL] [Abstract][Full Text] [Related]
13. Primaquine metabolism by human liver microsomes: effect of other antimalarial drugs.
Bangchang KN; Karbwang J; Back DJ
Biochem Pharmacol; 1992 Aug; 44(3):587-90. PubMed ID: 1510705
[TBL] [Abstract][Full Text] [Related]
14. In Vitro Activities of Primaquine-Schizonticide Combinations on Asexual Blood Stages and Gametocytes of Plasmodium falciparum.
Cabrera M; Cui L
Antimicrob Agents Chemother; 2015 Dec; 59(12):7650-6. PubMed ID: 26416869
[TBL] [Abstract][Full Text] [Related]
15. Effects of primaquine on hepatic microsomal haemoproteins and drug oxidation.
Murray M; Farrell GC
Toxicology; 1986 Dec; 42(2-3):205-17. PubMed ID: 3798469
[TBL] [Abstract][Full Text] [Related]
16. Primaquine disposition in the isolated perfused rat liver: effect of mefloquine induced bile flow reduction.
Coleman MD; Fleckenstein L; Heiffer MH
Biopharm Drug Dispos; 1989; 10(2):153-64. PubMed ID: 2784984
[TBL] [Abstract][Full Text] [Related]
17. Mechanistic aspects of the inhibition of microsomal drug oxidation by primaquine.
Murray M; Farrell GC
Biochem Pharmacol; 1986 Jul; 35(13):2149-55. PubMed ID: 3729971
[TBL] [Abstract][Full Text] [Related]
18. In vitro effects of quinoline derivatives on cytochrome P-450 and aminopyrine N-demethylase activity in rat hepatic microsomes.
Murray M
Biochem Pharmacol; 1984 Oct; 33(20):3277-81. PubMed ID: 6487376
[TBL] [Abstract][Full Text] [Related]
19. Mefloquine metabolism by human liver microsomes. Effect of other antimalarial drugs.
Bangchang KN; Karbwang J; Back DJ
Biochem Pharmacol; 1992 May; 43(9):1957-61. PubMed ID: 1596283
[TBL] [Abstract][Full Text] [Related]
20. Clarithromycin enhances the antimalarial efficacy of mefloquine via its increased bioavailability and disrupting P. falciparum apicoplast.
Gunjan S; Singh SK; Chauhan BS; Pandey SK; Ahmad H; Dwivedi AK; Tripathi R
Life Sci; 2015 Sep; 136():126-32. PubMed ID: 26164186
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
